Parnell Pharmaceuticals prices IPO at $10, well below the original range

By
A A A

Parnell Pharmaceuticals, an Australian maker of osteoarthritis and reproductive drugs for dogs, horses and cows, raised $50 million by offering 5.0 million shares at the revised $10 IPO price. The company had originally filed to offer 3.6 million shares at $17 to $19 before revising terms this morning. Parnell Pharmaceuticals will list on the NASDAQ under the symbol PARN. Jefferies andPiper Jaffray acted as joint bookrunners on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: PARN

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

89,070,840
  • $17.26 ▲ 3.23%
78,931,485
  • $7.02 ▲ 4.46%
77,555,734
  • $6.70 ▲ 6.69%
77,025,346
  • $24.66 ▲ 0.69%
74,713,335
  • $101.80 ▲ 1.82%
72,324,726
  • $7.64 ▲ 0.79%
57,112,188
  • $17.84 ▲ 55.27%
53,321,397
  • $18.01 ▼ 4.46%
As of 12/17/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com